Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | -1.64% | -2.28% | -6.83% |
04-30 | B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
04-29 | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.83% | 216M | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562